Subscription needed to view full article.

Venrock joins the biotech VC fundraising game, tossing $447M into a $4.3B pot of new money

It’s not unusual to find the partners at Venrock traveling in the A-list section of biotech. They like to find some of the more mature startups headed toward IPOs or some new arrivals on the public market — sticking with deep-pocket investors looking to do big things. And they clearly have a big appetite for rounds that can range up into the stratosphere.

Full Article